文献速递瓣膜外科

累及瓣间纤维体的感染性心内膜炎复杂重建手术五年结局

Five-year outcomes following complex reconstructive surgery for infective endocarditis involving the intervalvular fibrous body.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-01-01

本研究评估127例因双瓣感染性心内膜炎累及瓣间纤维体(IFB)行双瓣置换联合IFB补片重建患者的5年结局。30天和90天死亡率分别为28.3%和37.0%,3年和5年生存率分别为45.3±5.1%和41.8±5.8%,术后90天存活者分别为75.8±6.1%和70.0±8.0%。5年免再手术率为85.1±5.7%。

要点

  • 复杂IE累及IFB行双瓣置换加IFB重建,术后90天内死亡风险高。
  • 术前金黄色葡萄球菌感染和LVEF<35%预测30天死亡。
  • 术后90天存活者远期生存和免再手术率可接受。

核心结论

  • 双瓣置换联合IFB重建治疗复杂IE手术挑战大,术后90天内并发症和死亡率高,此后生存和免再手术率可接受。

研究设计与样本

  • 回顾性队列研究,纳入1999年1月至2018年12月共127例连续患者,均因活动性复杂IE行双瓣置换联合IFB重建。

主要发现

  • 患者平均年龄65.3±12.9岁,术前心源性休克和脓毒症分别占17.3%和18.9%,81.3%有既往心脏手术史。
  • 30天和90天死亡率分别为28.3%和37.0%。
  • 全部患者3年和5年生存率分别为45.3±5.1%和41.8±5.8%;术后90天存活者分别为75.8±6.1%和70.0±8.0%。
  • 5年免再手术率为85.1±5.7%。
  • 30天死亡预测因素为金黄色葡萄球菌感染(OR 1.65;P=0.04)和LVEF<35%(OR 12.06;P=0.03);90天死亡预测因素为需透析的急性肾损伤(OR 6.2;P=0.02)和LVEF<35%(OR 9.66;P=0.03);远期死亡预测因素为心源性休克(HR 2.46;P=0.01)。

临床怎么用

  • 对累及IFB的复杂IE,术前应评估金黄色葡萄球菌感染、LVEF<35%、需透析的急性肾损伤和心源性休克等高风险因素。
  • 术后90天是关键监测窗口,需加强并发症防治。
  • 术后90天存活者远期生存和免再手术率可接受,可据此进行随访咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Destruction of the intervalvular fibrous body (IFB) due to infective endocarditis (IE) warrants a complex operation involving radical debridement of all infected tissue, followed by double valve replacement (aortic and mitral valve replacement) with patch reconstruction of the IFB. This study assesses the 5-year outcomes in patients undergoing this complex procedure for treatment of double valve IE with IFB involvement. METHODS: A total of 127 consecutive patients underwent double valve replacement with reconstruction of the IFB for active complex IE between January 1999 and December 2018. Primary outcomes were 3-year and 5-year survival, as well as 5-year freedom from reoperation. RESULTS: Patients' mean age was 65.3 ± 12.9 years. Preoperative cardiogenic shock and sepsis were present in 17.3% and 18.9%, respectively. The majority of patients (81.3%) had undergone previous cardiac surgery. Overall, 30-day and 90-day mortality rates were 28.3% and 37.0%, respectively. The 3- and 5-year survival rates for all patients were 45.3 ± 5.1% and 41.8 ± 5.8%, and for those who survived the first 90 postoperative days 75.8 ± 6.1% and 70.0 ± 8.0%, respectively. The overall 5-year freedom from reoperation was 85.1 ± 5.7%. Preoperative predictors for 30-day mortality were Staphylococcus aureus [odds ratio (OR) 1.65; P = 0.04] and left ventricular ejection fraction (LVEF) <35% (OR 12.06; P = 0.03), for 90-day mortality acute kidney injury requiring dialysis (OR 6.2; P = 0.02) and LVEF <35% (OR 9.66; P = 0.03) and for long-term mortality cardiogenic shock (hazard ratio 2.46; P = 0.01). CONCLUSIONS: Double valve replacement with reconstruction of the IFB in patients with complex IE is a challenging operation associated with high morbidity and mortality, particularly in the first 90 days after surgery. Survival and freedom from reoperation rates are acceptable thereafter, particularly considering the severity of disease and complex surgery.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Davierwala PM, Marin-Cuartas M, Misfeld M, et al. Five-year outcomes following complex reconstructive surgery for infective endocarditis involving the intervalvular fibrous body. Eur J Cardiothorac Surg. 2020. PMID: 32380545. doi:10.1093/ejcts/ezaa146

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。